Shell Asset Management CO Supernus Pharmaceuticals, Inc. Transaction History
Shell Asset Management CO
- $2.2 Billion
- Q1 2024
A detailed history of Shell Asset Management CO transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 9,876 shares of SUPN stock, worth $303,687. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,876
Previous 10,498
5.92%
Holding current value
$303,687
Previous $358,000
26.26%
% of portfolio
0.01%
Previous 0.02%
Shares
22 transactions
Others Institutions Holding SUPN
# of Institutions
255Shares Held
59.2MCall Options Held
47.9KPut Options Held
13.1K-
Black Rock Inc. New York, NY10.4MShares$320 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.14MShares$189 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.27MShares$162 Million1.83% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.87MShares$88.2 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.68MShares$82.4 Million0.08% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.64B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...